CVS Caremark has reached a settlement agrement with Department of Jutice to resolve an investigation
into the practice of dispensing the generic ranitidine in capsule rather than tablet form
CVS Caremark Corp. to pay almost $37 million on retail dispensing practices for ranitidine
Submitted by eport on Mon, 04/14/2008 - 04:00.
»
- Login or register to post comments
- Feed: Late Breakers: Drug Topics
- Original article